JPRN-UMIN000007371
Completed
未知
Prospective evaluation of renal function and proteinuria in chronic kidney disease patients - Prospective evaluation of renal function and proteinuria in chronic kidney disease patients (PERFECT study)
Aichi welfare agricultural cooperative association Anjo Kosei Hospital0 sites60 target enrollmentFebruary 24, 2012
ConditionsProteinuria
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Proteinuria
- Sponsor
- Aichi welfare agricultural cooperative association Anjo Kosei Hospital
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patient who caused acute coronary syndrome within six months. The patient of an inflammatory disorder, infection, and a malignant tumor. The patient who has an anamnesis of hypersensitivity to atorvastatin and/or rosuvastatin. A pregnant woman or the woman that may have become pregnant, and a nursing mother. A patient with critical impaired liver function and renal dysfunction.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prognostic evaluation with focus on renal function of molecular target drugs for Unresectable or Metastatic Renal Cell Carcinoma patients with Renal DysfunctioJPRN-UMIN000021981Shinshu University school of medicine30
Recruiting
Not Applicable
Examination of the effects on renal function and prognosis of various diuretics for liver cirrhosisiver cirrhosisJPRN-UMIN000040179Hokkaido University400
Completed
Not Applicable
Retrospective study to assess renal function using MAG3 renogram in patients with renal tumor who treated by carbon ion radiotherapyRenal tumorJPRN-UMIN000039928ational Institute of Radiological Sciences (NIRS), QST20
Completed
Not Applicable
rinary neutrophil gelatinase-associated lipocalin(NGAL) excretion and Renal Functions in Mild Maternal HydronephrosisMild Maternal Hydronephrosis in PregnancyRenal and Urogenital - Kidney diseaseReproductive Health and Childbirth - Fetal medicine and complications of pregnancyACTRN12614000455662Emre Goksan Pabuccu86
Active, not recruiting
Phase 1
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2014-005033-31-FRAddmedica S.A.S